title: Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised,   double-blind phase III trial.  Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators.
authors.affiliation: University of Texas Southwestern, Dallas, TX, USA. Shahrokh.Shariat@UTSouthwestern.edu
authors.forename: Shahrokh F
authors.initials: SF
authors.lastname: Shariat
authors.forename: Christian
authors.initials: C
authors.lastname: Bolenz
authors.forename: Pierre I
authors.initials: PI
authors.lastname: Karakiewicz